期刊文献+

肾上腺素对氯普鲁卡因硬膜外阻滞患者药效学和药代动力学的影响 被引量:3

Pharmacokinetics and pharmacodynamks of chloroprocaine with or without epinephrine for epidural blockade
原文传递
导出
摘要 目的观察1:20万肾上腺素对3%盐酸氯普鲁卡因硬膜外阻滞患者药效学和药代动力学的影响。方法择期行下腹部手术患者20例,ASAⅠ或Ⅱ级,随机分为2组(n=10):盐酸氯普鲁卡因组(C组)和盐酸氯普鲁卡因加肾上腺素组(CE组)。分别用3%氯普鲁卡因6 mg·kg-1(C组)和含 1:20万肾上腺素3%氯普鲁卡因6 mg·kg-1(CE组)硬膜外阻滞,记录局麻药的起效时间、运动阻滞起效时间和给药后20min时运动阻滞程度;分别在给药前及给药后3、6、9、11、13、15、17、20、30、45、60、 90min采取桡动脉血1.5ml,高效液相色谱法检测血浆氯普鲁卡因浓度,经计算机软件拟合血药浓度 -时间曲线,并计算各项药代动力学参数。结果两组局麻药的起效时间、运动阻滞起效时间和运动阻滞程度差异无统计学意义。C、CE组血药浓度峰值(Cmax)分别为0.49±0.47、(0.32±0.22)mg· L-1,达峰值时间(Tmax)分别为8±3、(9±4)min;血药浓度曲线下面积(AUC)分别为10±6、(7±4)μg· min·ml-1;清除速率常数(K)分别为0.32±0.21、(0.36±0.32)min-1;两组间Cmax、Tmax、AUC及K比较差异无统计学意义(P>0.05)。结论 1:20万肾上腺素对3%盐酸氯普鲁卡因硬膜外阻滞的药代动力学和药效学没有影响。 Objective To determine the pharmacokinetics and pbarmacodynamics of chloroprocaine with or without epinephrine for epidural blockade. Methods Twenty ASA physical status Ⅰ or Ⅱ patients of both sexes aged 37-55 yrs weighing 45-80 kg undergoing elective lower abdominal surgery were randomly divided into 2 groups ( n = 10 each) : group C chloroprocaine without epinephrine and group CE chloroprocaine with epinephrine. The epidural catheter was inserted into epidural space at T12-L4 and advanced toward head for about 4 cm. After correct epidural placement was confirmed, 3 % chloroprocaine 6 mg·kg^-1 with or without 1 : 200 000 epinephrine was injected into epidural space over 2 min. Onset time of analgesia , motor blockade and degree of motor blockade at 20 min after epidural injection (Bromage scale 0 = no motor block, 3 = unable to flex hip, knee and ankle) were recorded. Blood samples were taken from radial artery before and at 3, 6, 9, 11, 13, 15, 17, 20, 30, 45, 60, 90 min after epidural injection for determination of plasma chloroprocaine concentration by HPLC. Results The two groups were comparable with respect to demographic data. There were no significant differences in the pharmokinetics and pharmacodynamics of chloroprocaine between the two groups. The Cmax was (0.491±0.47) mg·L^-1 and (0.32±0.22) mg·L^-1; The Tmax was (8±3) min and (9±4) min; the AUC was (10±6) μg·min·ml^-1 and (7± 4) μg·min· ml^-1 ; the K was 0.32 ± 0.21 min^-1 and 0.36 ± 0.32 min^-1 in group C and CE respectively. Conclusion Epinephrine 1 : 200 000 does not affect the pharmacokinetics and pharmacodynamics of 3 % chloroprocaine for epidural block.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2006年第5期414-416,共3页 Chinese Journal of Anesthesiology
关键词 普鲁卡因 肾上腺素 麻醉 硬膜外 药代动力学 Procaine Epinephrine Anesthesia, epidural Pharmacokinetics
  • 相关文献

参考文献9

  • 1庄心良 曾因明 陈伯銮.现代麻醉学(第3版)[M].北京:人民卫生出版社,2004.1956.
  • 2施伟忠,张蕾蕾.硬膜外阻滞时利多卡因生物利用度的研究[J].中华麻醉学杂志,1993,13(3):163-165. 被引量:3
  • 3涂恩平,吴新民,解大建,胡晓华.罗哌卡因含或不含肾上腺素硬膜外麻醉的药效学和药代动力学[J].中华麻醉学杂志,1999,19(12):714-716. 被引量:13
  • 4顾健,高秀梅,张海英,李玉珍.反相高效液相法测定氯普鲁卡因血浆药物浓度[J].药物分析杂志,2005,25(1):17-20. 被引量:3
  • 5Ruetsch YA, Boni T, Borgeat A. From cocaine to ropivacaine: the history of local anesthetic drugs. Curr Top Med Chem, 2001, 1: 175-182.
  • 6Titkenhead AK, Smith G, eds. Textbook of anesthesia. 3rd edn. New York: Churchill Livingstone, 1996.235.
  • 7O'Brien JE, Abbey V, Hinsvark O, et al. Metabolism and measurement of chloroprocaine, an ester-type local anesthetic. J Pharm Sci, 1979,68:75-78.
  • 8Janicki PK, Johnson R, Kambam JR. Rapid determination of chloroprocaine and its major metabolite, 2-chloroaminobenzoic acid, in plasma by high-performance liquid chromatography. J Chromatogr B Biomed Appl, 1996 ,675:336-541.
  • 9Therese KA, Lasik DS. Comparative maternal, fetal and neonatal effects of chloroprocaine with and without epinephrine for epidural anesthesia in obstetrics. Anesth Analg, 1987, 66:71-75.

二级参考文献12

  • 1Knize DM, Fishell R. Use of preoperative subcutaneous "wetting solution" and epidural block anesthesia for liposuction in the office -based surgical suite. Pla.st Reeonstr Surg , 1997, I00( 7 ) : 1867.
  • 2Covino BG. Pharmacodynamic and phnmrcokinetic aspects of local anesthetics. Ann chir Gynecol , 1984,73 ( 3 ) : 118.
  • 3James E, O'brien, Vicki Abbey, Orville Hinsvark, et al. Metabolism and Measurement of chloroprcaine, an ester - Type local anesthetic. J Pharm Sci, 1979,68( I ) :75.
  • 4Janicki PK,Johnson R, Kambam JR. Rapid determination of chloroprocaine and its major metabolite, 2 - chloroaminobenzoic acid, in plasma by high - performance liquid chromatography. J Chromatogr B, 1996,675:336.
  • 5Tobin T,Blake JW, Sturma L, Amett S. Pharmacology of procaine in the horse:procaine esterase properties of equine plasma and synovial fluid. Am J Vet Res, 1976,37(I0) :1165.
  • 6解大建,中华外科杂志,1988年,26卷,324页
  • 7解大建,北京医科大学学报,1986年,18卷,275页
  • 8夏文江,1986年
  • 9解大建,北京医科大学学报,1999年,31卷,287页
  • 10谢荣,麻醉学(第3版),1994年,144页

共引文献48

同被引文献17

  • 1Macdonald R,陈伯銮.阿斯匹林与硬膜外阻滞[J].国际麻醉学与复苏杂志,1992,26(3):157-159. 被引量:1
  • 2郑敏理,阿孜古丽,吴桂兰.硬膜外导管可疑误入硬膜外静脉引起局麻药毒性反应6例报道[J].临床麻醉学杂志,2005,21(4):280-281. 被引量:5
  • 3高秀梅,杨拔贤,顾健,冯艺.氯普鲁卡因硬膜外阻滞时的药效学和药代动力学[J].临床麻醉学杂志,2007,23(5):379-381. 被引量:15
  • 4傅润乔,田玉科,徐建国.认识氯普鲁卡因[J].临床麻醉学杂志,2007,23(5):437-438. 被引量:48
  • 5李美琴.硬膜外阻滞用于削宫产时硬膜外出血后影响麻醉效果.临床麻醉学杂志,1993,9(4):182-182.
  • 6Griffin R M, Scott RPF. A comparison between the middle and pararnedian approaches to the extradural space [ J ]. Anaesthesia, 1984, 39: 584.
  • 7Guinard J P, Mulroy M F, Carpenter R L, et al. Test doses: optimal epinephrine content with and without acute beta - adrenergie blockade[J]. Anesthesiology, 1990, 73 : 386.
  • 8徐亨昭 余金甫.椎管内阻滞辅用肾上腺素的近况.国外医学:麻醉学与复苏分册,1988,9(6):332-332.
  • 9刘树孝 王景阳.硬膜外阻滞所用局麻药加肾上腺素的效果分析.国外医学:麻醉学与复苏分册,1987,8(1):9-9.
  • 10Palmer G M, Cairns B E, Berkes S L, et al. The effects of lidocaine and adranergic on rat sciatic nerve and skeletal muscle blood flow in vivo [ J ]. Anesth Analg, 2002, 95 ( 6 ) : 1080.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部